Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Meet OPEN Health and Pharmerit Experts at the World Orphan Drug Virtual USA Congress

August 24, 2020 |  

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:

Advanced Therapies Commercial: Tuesday, August 25
Succeeding with Star Wars Medicine: Translating the Science and Value of Gene Therapy to Key Stakeholders
Gavin Jones, Director of Rare Disease, OPEN Health

PANEL: Wednesday, August 26
Bridging the Clinical Evidence Gap for Payers – Examining Recent Cases of Real-World Evidence for Reimbursement
Shelby Corman, Real-World Evidence and Data Analytics Lead, Pharmerit

Pink divider

OPEN Health is the only integrated agency that combines the depth of rare disease knowledge with the breath of discipline expertise across medical affairs, commercial, HEOR and market access.

OPEN Health’s Evidence and Access practice is a best in class global HEOR and market access consultancy that specialises in identifying client critical issues and building bespoke integrated solutions to support companies operating in rare disease and improve patient outcomes.

The Patient and Brand Communications practice at OPEN Health combines a deep focus in patient engagement (patient journey mapping and patient support programmes), PR (brand, disease awareness, corporate and internal communications) and advertising.

The Medical Communications practice provides expertise in Medical Affairs content and consultancy, publication planning and management, medical education, and internal training.

In addition to extensive rare disease experience we have delivered projects for over half the advanced therapies that have been launched in the United States and Europe.

Pink divider

Our executive team will be available to speak with you regarding how OPEN Health and Pharmerit can support you in the fight against rare diseases. Contact Gavin Jones today to set up a meeting.

This content was provided by OPEN Health

Company Details

OPEN Health

OPEN Health

Email
Website

 Latest Content from  OPEN Health 

OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, announced a new team of experts will lead its HEOR & Market Access Scientific Office.

OPEN Health Appoints Richard Jones as President for Evidence & Access

OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.

Drive, Discover, Dive_OPEN Health

Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

The CM Group rebrands to OPEN Health

Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding...

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.

Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access

OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.

OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital

OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical...

How digital health is changing the relationship between patients and health providers | OPEN Health

The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes